Atlas Trials

Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer

Clinical trial NCT00414388 · COMPLETED

Trial details

NCT number
NCT00414388
Sponsor
Oncology Specialists, S.C.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2006-12-01
Primary completion
2011-09-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.